Part I Corporate Information We were incorporated under the laws of the State of Delaware in 2003. Our company, formerly known as GlycoMimetics, Inc., is a biotechnology company that is the result of a reverse recapitalization transaction with a private company named Crescent Biopharma, Inc. (Pre-Merger Crescent). Prior to the reverse recapitalization transaction, Pre-Merger Crescent was established and incorporated under the laws of the state of Delaware on September 19, 2024. On June 16, 2025,...
Q2 FY2026 — expected 2026-07-28
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001628280-26-011983 | EDGAR | 121K words |
| 2025-02-13 | 2024-12-31 | 0001558370-25-000948 | EDGAR | — |
| 2024-03-27 | 2023-12-31 | 0001558370-24-004013 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0001558370-23-004864 | EDGAR | — |
| 2022-03-03 | 2021-12-31 | 0001558370-22-002737 | EDGAR | — |
| 2021-03-02 | 2020-12-31 | 0001558370-21-002222 | EDGAR | — |
| 2020-02-28 | 2019-12-31 | 0001558370-20-001723 | EDGAR | — |
| 2019-03-06 | 2018-12-31 | 0001558370-19-001537 | EDGAR | — |
| 2018-03-06 | 2017-12-31 | 0001558370-18-001553 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0001558370-17-001198 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001628280-25-049868 | EDGAR | 57K words |
| 2025-07-31 | 2025-06-30 | 0001628280-25-036839 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001558370-25-007780 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001558370-24-015537 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011579 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007632 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001558370-23-017505 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0001558370-23-012814 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0001558370-23-007744 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001558370-22-017036 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001558370-22-011770 | EDGAR | — |
| 2022-04-28 | 2022-03-31 | 0001558370-22-006260 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-26 | 0001628280-26-011988 | EDGAR | 3K words |
| 2025-12-04 | 0001628280-25-055221 | EDGAR | — |
| 2025-11-06 | 0001628280-25-049865 | EDGAR | — |
| 2025-07-31 | 0001628280-25-036846 | EDGAR | — |
| 2025-06-18 | 0001104659-25-060714 | EDGAR | — |
| 2025-06-06 | 0001104659-25-057078 | EDGAR | — |
| 2025-05-30 | 0001104659-25-054587 | EDGAR | — |
| 2025-04-29 | 0001104659-25-040386 | EDGAR | — |
| 2025-02-25 | 0001558370-25-001517 | EDGAR | — |
| 2025-02-14 | 0001558370-25-001016 | EDGAR | — |
188 total filings indexed. 156 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001253689 |
| Ticker | CBIO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | E9 |
| Website | https://www.crescentbiopharma.com |
| Listed | 2025-06-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report